FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2398668669> ?p ?o ?g. }

• W2398668669 endingPage "93" @default.
• W2398668669 startingPage "389" @default.
• W2398668669 abstract "We have studied the effect of different doses of 1 alpha-hydroxycalciferol (1 alpha [OH]D3) on bone mineral density (BMD) of 165 male hemodialysis patients (ages from 24 to 71 years) using dual X-ray absorptiometry (DXA) in a one-year follow-up study. There were no fractures in their lumbar spine participated in the study. 1 alpha (OH)D3 was administered orally at a low dose (0.25 microgram/day, n = 56, Group L) or at a higher dose (0.5 to 1.0 microgram/day, average 0.58 +/- 0.02 microgram/day, n = 65, Group H), and the absolute BMD values and the percent annual changes of BMD were compared with those who took no 1 alpha (OH)D3 (n = 44, Group N). BMD was measured three ways at the start and the end of the study; 1) lumbar spine BMD at anterior-posterior view (AP-BMD), 2) lumbar spine BMD at lateral view (Lat-BMD), and 3) 1/3 distal radius BMD. Plain spinal radiographs indicated no bone fracture before nor during the study. Although there were no detectable changes in the absolute values of BMD during the one-year period, significant differences were observed in the percent annual changes of lumbar spine BMD among the three groups. The annual changes of lumbar spine BMD among the three groups. The annual changes of AP-BMD were -0.4 +/- 0.7%, +0.1 +/- 0.6%, and +2.4 +/- 0.8% in Group N, Group L and Group H, respectively. These changes were statistically significant (p = 0.011 by one-way ANOVA). The positive effect of 1 alpha (OH)D3 on Lat-BMD was also significant (p = 0.028 by one-way ANOVA), while the treatment did not affect the change of BMD at 1/3 distal radius. There was no significant difference among the three groups in the initial or final levels of biochemical parameters including serum calcium, phosphorus, alkaline phosphatase, osteocalcin and parathyroid hormone. These results indicate, in male hemodialysis patients, that oral 1 alpha (OH)D3 treatment is effective in the prevention of lumbar spine BMD loss which is frequently observed in hemodialysis patients." @default.
• W2398668669 created "2016-06-24" @default.
• W2398668669 creator A5005697353 @default.
• W2398668669 creator A5014568078 @default.
• W2398668669 creator A5029886810 @default.
• W2398668669 creator A5036692194 @default.
• W2398668669 creator A5072564461 @default.
• W2398668669 date "1996-12-01" @default.
• W2398668669 modified "2023-09-26" @default.
• W2398668669 title "The effect of oral 1 alpha-hydroxycalciferol treatment on bone mineral density in hemodialysis patients." @default.
• W2398668669 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8982555" @default.
• W2398668669 hasPublicationYear "1996" @default.
• W2398668669 type Work @default.
• W2398668669 sameAs 2398668669 @default.
• W2398668669 citedByCount "7" @default.
• W2398668669 countsByYear W23986686692013 @default.
• W2398668669 countsByYear W23986686692022 @default.
• W2398668669 crossrefType "journal-article" @default.
• W2398668669 hasAuthorship W2398668669A5005697353 @default.
• W2398668669 hasAuthorship W2398668669A5014568078 @default.
• W2398668669 hasAuthorship W2398668669A5029886810 @default.
• W2398668669 hasAuthorship W2398668669A5036692194 @default.
• W2398668669 hasAuthorship W2398668669A5072564461 @default.
• W2398668669 hasConcept C126322002 @default.
• W2398668669 hasConcept C126894567 @default.
• W2398668669 hasConcept C141071460 @default.
• W2398668669 hasConcept C2776541429 @default.
• W2398668669 hasConcept C2776886416 @default.
• W2398668669 hasConcept C2778063415 @default.
• W2398668669 hasConcept C2779329777 @default.
• W2398668669 hasConcept C2779835254 @default.
• W2398668669 hasConcept C2989005 @default.
• W2398668669 hasConcept C3017433307 @default.
• W2398668669 hasConcept C44575665 @default.
• W2398668669 hasConcept C71924100 @default.
• W2398668669 hasConceptScore W2398668669C126322002 @default.
• W2398668669 hasConceptScore W2398668669C126894567 @default.
• W2398668669 hasConceptScore W2398668669C141071460 @default.
• W2398668669 hasConceptScore W2398668669C2776541429 @default.
• W2398668669 hasConceptScore W2398668669C2776886416 @default.
• W2398668669 hasConceptScore W2398668669C2778063415 @default.
• W2398668669 hasConceptScore W2398668669C2779329777 @default.
• W2398668669 hasConceptScore W2398668669C2779835254 @default.
• W2398668669 hasConceptScore W2398668669C2989005 @default.
• W2398668669 hasConceptScore W2398668669C3017433307 @default.
• W2398668669 hasConceptScore W2398668669C44575665 @default.
• W2398668669 hasConceptScore W2398668669C71924100 @default.
• W2398668669 hasIssue "6" @default.
• W2398668669 hasLocation W23986686691 @default.
• W2398668669 hasOpenAccess W2398668669 @default.
• W2398668669 hasPrimaryLocation W23986686691 @default.
• W2398668669 hasRelatedWork W2359663220 @default.
• W2398668669 hasRelatedWork W2372687130 @default.
• W2398668669 hasRelatedWork W2381621119 @default.
• W2398668669 hasRelatedWork W2382175455 @default.
• W2398668669 hasRelatedWork W2387187329 @default.
• W2398668669 hasRelatedWork W2392968299 @default.
• W2398668669 hasRelatedWork W2395961887 @default.
• W2398668669 hasRelatedWork W243161752 @default.
• W2398668669 hasRelatedWork W2980350717 @default.
• W2398668669 hasRelatedWork W3032661888 @default.
• W2398668669 hasVolume "46" @default.
• W2398668669 isParatext "false" @default.
• W2398668669 isRetracted "false" @default.
• W2398668669 magId "2398668669" @default.
• W2398668669 workType "article" @default.